Skin Carcinoma — Trials

Skin Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

389 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 127
Recruiting: 69
Ph III recruiting: 8
Growth YoY: +12%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07144384	Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma	completed	Early Phase 1	4	Ohio State University Comprehensive Cancer CenterOTHER	1	Sep 28, 2026	clinicaltrials
NCT04480645	CivaDerm(TM) Surface Therapy Pilot Study	completed	Early Phase 1	10	CivaTech OncologyINDUSTRY	1	Mar 24, 2026